The Ensign Group, Inc.
NASDAQ:ENSGMedical - Care Facilities
-$1.09 today
- Market cap
- $10.68B
- Beta
- 0.68
- P/E (TTM)
- 24.8
- EPS (TTM)
- $6.29
- Dividend yield
- 0.16%
Volume 0.27M
Average 0.56M
ENSG Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
The Ensign Group, Inc.NASDAQ: ENSG
Depreciation & Amortization · Q2 FY2026 · quarter ended Jun 2026
Depreciation & amortization grows in line with its trailing trend
Q2 FY2026 depreciation & amortization of $31.41M rose 21.8% year over year, in line with the +21.9% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 9.0% from the prior quarter. Over 3 fiscal years it compounded at +18.7% a year.
Context
- Depreciation & amortization amounted to 2.1% of revenue in FY2025, unchanged from a year earlier.
- Depreciation & amortization increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +21.8% toward the trailing-twelve-month pace of +21.9%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 104.33M USD
- Year-over-year change
- +24.0%
- 4-year CAGR
- +16.8%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 104.33M | +24.0% |
| FY2024 | 2024-12-31 | 84.14M | +16.2% |
| FY2023 | 2023-12-31 | 72.39M | +16.1% |
| FY2022 | 2022-12-31 | 62.36M | +11.4% |
| FY2021 | 2021-12-31 | 55.99M | — |
Depreciation & Amortization vs competitors
How ENSG compares with its peers on the latest reported figures
- ENSG's LTM Jun 2026 depreciation & amortization of $114.56M is the 5th largest of the 11 companies compared; the peer median is $67.2M.
- Its year-over-year change of +21.9% is the 4th highest of 11, against a peer median of +8.6%.
- Depreciation & amortization amounts to 2.1% of revenue for ENSG, versus a peer median of 2.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $3.67B | +7.4% | +5.9% | 4.7% | |
| LTM Sep 2026 | $735.2M | +90.4% | +1.5% | 24.9% | |
| LTM Mar 2026 | $435M | -8.6% | -7.3% | 2.0% | |
| LTM Jun 2026 | $346.5M | +9.8% | +10.4% | 5.6% | |
| LTM Jun 2026 | $114.56M | +21.9% | +18.7% | 2.1% | |
| LTM Jun 2026 | $67.98M | +37.8% | +35.6% | 1.2% | |
| LTM Jun 2026 | $66.42M | +4.1% | +3.1% | 2.6% | |
| LTM Sep 2026 | $49.13M | +10.2% | +3.5% | 3.1% | |
| LTM Oct 2026 | $30.08M | +6.5% | -10.1% | 1.1% | |
| LTM Mar 2026 | $19.81M | -8.6% | +10.8% | 2.1% | |
| LTM Mar 2026 | $12.91M | +93.3% | +20.3% | 1.3% | |
| Peer median (excluding ENSG) | $67.2M | +8.6% | +4.7% | 2.3% | |
Competitors are the stored peer set for ENSG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 197.73M | 224.65M | 209.85M | 298.46M | 344.26M |
| Depreciation & Amortization | 55.99M | 62.36M | 72.39M | 84.14M | 104.33M |
| Deferred Income Tax | (24.88M) | (6.5M) | (27.48M) | 635K | (16.86M) |
| Stock-Based Compensation | 18.68M | 22.72M | 30.77M | 36.23M | 48.3M |
| Change in Working Capital | 33K | (36.94M) | 37.89M | (75.16M) | 77.92M |
| Accounts Receivables | (30.77M) | (82.43M) | (79.82M) | (84.4M) | (70.43M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 7.12M | 17.87M | 15.92M | 2.84M | (2.92M) |
| Other Working Capital | 23.69M | 27.61M | 101.79M | 6.41M | 151.28M |
| Other Non-Cash Items | 28.14M | 6.23M | 53.25M | 2.89M | 6.31M |
| Operating Cash Flow | 275.68M | 272.51M | 376.67M | 347.19M | 564.27M |
| Capital Expenditures | (69.55M) | (87.55M) | (106.18M) | (158.24M) | (193.56M) |
| Acquisitions (Net) | (7.98M) | (16.4M) | 0 | 0 | 0 |
| Purchases of Investments | (32.26M) | (21.98M) | (30.82M) | (105.15M) | (110.72M) |
| Sales of Investments | 27.48M | 14.36M | 18.85M | 26.4M | 99.67M |
| Other Investing Activities | (91.6M) | (74.62M) | (64.55M) | (153.06M) | (308.57M) |
| Investing Cash Flow | (173.91M) | (186.18M) | (182.7M) | (390.05M) | (513.18M) |
| Debt Repayment | 42.16M | (3.7M) | (3.88M) | (3.95M) | (4.09M) |
| Common Stock Issued | 0 | 6.69M | 0 | 0 | 29.04M |
| Common Stock Repurchased | (11.83M) | (31.58M) | (1.93M) | (1.21M) | (21.43M) |
| Dividends Paid | (11.55M) | (12.17M) | (12.89M) | (13.67M) | (14.41M) |
| Other Financing Activities | (94.92M) | 2.51M | 18.09M | 16.67M | (924K) |
| Financing Cash Flow | (76.14M) | (32.26M) | (612K) | (2.16M) | (11.81M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 25.64M | 54.07M | 193.36M | (45.03M) | 39.28M |
| Free Cash Flow | 206.13M | 184.97M | 270.49M | 188.95M | 370.71M |
The Ensign Group, Inc.
NASDAQ:ENSG
Intrinsic Alpha fair value
Locked
Current Price
$182.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.